October 10, 2025 - 11:54

Japan’s Finance Minister Katsunobu Kato has intensified his warnings regarding the fluctuations of the yen, following the currency's decline to a new eight-month low against the dollar. This significant drop occurred early Friday, raising alarm bells within the government and financial sectors. The recent depreciation of the yen has sparked concerns about its potential impact on the economy, prompting Kato to address the issue more forcefully.
Despite attempts by the ruling party's new leader to reassure markets, the yen's continued weakness has led to heightened scrutiny. Analysts are closely monitoring the situation, as a weaker yen can increase the cost of imports and complicate inflationary pressures. Kato's statements reflect a growing urgency to stabilize the currency and restore confidence among investors. The Japanese government is under pressure to implement measures that may help to curb the yen's decline and support the overall economic stability of the nation.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...